Skip to content

Clinical trials

Phase 1/2 Cholangiocarcinoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 1/2 Country / region: Italy Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20171
20202
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alentis Therapeutics AG1
Amgen1
Basilea Pharmaceutica1
Bold Therapeutics, Inc.1
Elevar Therapeutics1
Istituto Clinico Humanitas1
Taiho Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma7
Colorectal Neoplasms2
Stomach Neoplasms2
Adenocarcinoma of Lung1
Biliary Tract Neoplasms1
Breast Neoplasms1
Carcinoma, Ovarian Epithelial1
Carcinoma, Transitional Cell1
Liver Neoplasms1
Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.